A detailed history of Janus Henderson Group PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,767,417 shares of RPRX stock, worth $46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,767,417
Previous 1,852,660 4.6%
Holding current value
$46 Million
Previous $56.3 Million 17.17%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $2.24 Million - $2.55 Million
-85,243 Reduced 4.6%
1,767,417 $46.6 Million
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $1.32 Million - $1.5 Million
-47,954 Reduced 2.52%
1,852,660 $56.3 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $8.8 Million - $9.81 Million
-335,782 Reduced 15.01%
1,900,614 $53.4 Million
Q3 2023

Nov 14, 2023

SELL
$26.26 - $31.38 $990,107 - $1.18 Million
-37,704 Reduced 1.66%
2,236,396 $60.7 Million
Q2 2023

Aug 14, 2023

SELL
$29.6 - $36.56 $8.58 Million - $10.6 Million
-289,895 Reduced 11.31%
2,274,100 $69.9 Million
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $1.2 Million - $1.44 Million
-36,506 Reduced 1.4%
2,563,995 $92.4 Million
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $6.41 Million - $7.2 Million
-163,580 Reduced 5.92%
2,600,501 $103 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $13.7 Million - $15.3 Million
-342,520 Reduced 11.03%
2,764,081 $111 Million
Q2 2022

Aug 15, 2022

BUY
$37.53 - $44.22 $12.2 Million - $14.3 Million
323,775 Added 11.63%
3,106,601 $131 Million
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $7.97 Million - $9.02 Million
212,647 Added 8.27%
2,782,826 $108 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $7.31 Million - $8.83 Million
207,885 Added 8.8%
2,570,179 $102 Million
Q3 2021

Nov 16, 2021

SELL
$36.14 - $42.24 $50 Million - $58.4 Million
-1,383,120 Reduced 36.93%
2,362,294 $85.4 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $99.8 Million - $117 Million
2,505,360 Added 202.04%
3,745,414 $154 Million
Q1 2021

May 17, 2021

SELL
$42.34 - $52.82 $155 Million - $193 Million
-3,661,646 Reduced 74.7%
1,240,054 $54.1 Million
Q4 2020

Feb 16, 2021

BUY
$36.12 - $50.05 $6.4 Million - $8.86 Million
177,056 Added 3.75%
4,901,700 $245 Million
Q3 2020

Nov 16, 2020

BUY
$38.56 - $48.36 $8.39 Million - $10.5 Million
217,506 Added 4.83%
4,724,644 $199 Million
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $201 Million - $235 Million
4,507,138 New
4,507,138 $219 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.4B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.